Literature DB >> 18974564

Study of idiopathic inflammatory myopathies with special reference to borderland between idiopathic inflammatory myopathies and muscular dystrophies.

Satish V Khadilkar1, Shekhar G Patil, Sanjeev N Amin.   

Abstract

BACKGROUND: Idiopathic inflammatory myopathies (IIMs) form important treatable myopathies, hence it is important to recognize and categorize them. In some cases, the differential diagnosis between IIM and muscular dystrophies can be difficult. AIM: To study the clinical and laboratory features of patients with IIMs and compare and contrast this group with limb girdle muscular dystrophies (LGMDs). SETTING AND
DESIGN: A prospective study for the period of five years [1999-2004] was undertaken at a tertiary neuromuscular center.
MATERIALS AND METHODS: Bohan and Peter criteria were used for the diagnosis of IIM and Bushby criteria were used for the diagnosis of LGMD. Patients underwent history, clinical examination, hematological tests, electrophysiological studies and muscle biopsy. The biopsies were studied for histology and immunocytochemistry. A clinical scoring system was evolved to differentiate IIM from LGMD and was validated in a blinded manner. Receiver operator curves were used as the statistical method to analyze the sensitivity and specificity. RESULTS AND
CONCLUSIONS: In the IIM group, dermatomyositis was most common, followed by polymyositis, occurring in young females. Overlap group was less common. In patients with polymyositis, onset in upper girdle was associated with adverse outcome. The scoring system helped to differentiate IIM from LGMD, mainly using clinical pointers. This was particularly valuable in chronic cases.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18974564     DOI: 10.4103/0028-3886.43456

Source DB:  PubMed          Journal:  Neurol India        ISSN: 0028-3886            Impact factor:   2.117


  5 in total

Review 1.  Sporadic inclusion body myositis: variability in prevalence and phenotype and influence of the MHC.

Authors:  F L Mastaglia
Journal:  Acta Myol       Date:  2009-10

2.  Clinical and laboratory features distinguishing juvenile polymyositis and muscular dystrophy.

Authors:  Gulnara Mamyrova; James D Katz; Robert V Jones; Ira N Targoff; Peter A Lachenbruch; Olcay Y Jones; Frederick W Miller; Lisa G Rider
Journal:  Arthritis Care Res (Hoboken)       Date:  2013-12       Impact factor: 4.794

3.  Clinical, electrophysiologic, and histopathologic profile, and outcome in idiopathic inflammatory myositis: An analysis of 68 cases.

Authors:  K N Ramesha; Abraham Kuruvilla; P S Sarma; V V Radhakrishnan
Journal:  Ann Indian Acad Neurol       Date:  2010-10       Impact factor: 1.383

4.  Epidemiology and Natural History of Inclusion Body Myositis: A 40-Year Population-Based Study.

Authors:  Shahar Shelly; Michelle M Mielke; Jay Mandrekar; Margherita Milone; Floranne C Ernste; Elie Naddaf; Teerin Liewluck
Journal:  Neurology       Date:  2021-04-20       Impact factor: 11.800

Review 5.  Immune and myodegenerative pathomechanisms in inclusion body myositis.

Authors:  Christian W Keller; Jens Schmidt; Jan D Lünemann
Journal:  Ann Clin Transl Neurol       Date:  2017-05-16       Impact factor: 4.511

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.